Role of central and peripheral adenosine receptors in the cardiovascular responses to intraperitoneal injections of adenosine A 1 and A 2A subtype receptor agonists

British Journal of Pharmacology

Volumn 144, Issue 5, 2005, Pages 642-650

  Schindler, Charles W ^a   Karcz Kubicha, Marzena ^a   Thorndike, Eric B ^a   Müller, Christa E ^b   Tella, Srihari R ^c   Ferré, Sergi ^a   Goldberg, Steven R ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b UNIVERSITY OF BONN   (Germany)

^c Drug Enforcement Administration   (United States)

Author keywords

A 1 receptors; A 2A receptors; Blood pressure; CGS 21680; CPA; Heart rate

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 3 (3 HYDROXYPROPYL) 8 (3 METHOXYSTYRYL) 7 METHYL 1 PROPARGYLXANTHINE PHOSPHATE DISODIUM SALT; 6 N CYCLOPENTYLADENOSINE; 8 (4 SULFOPHENYL)THEOPHYLLINE; 8 CYCLOPENTYLTHEOPHYLLINE; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A2 RECEPTOR ANTAGONIST; ADENOSINE A2A RECEPTOR AGONIST; ADENOSINE RECEPTOR; CAFFEINE; MX 3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RESPONSE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG RECEPTOR BINDING; HEART RATE; MALE; MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; RAT; TELEMETRY;

ADENOSINE; ANIMALS; BLOOD PRESSURE; CAFFEINE; HEART RATE; INJECTIONS, INTRAPERITONEAL; MALE; PHENETHYLAMINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A1; RECEPTOR, ADENOSINE A2A; THEOPHYLLINE; XANTHINES;

EID: 15944405029     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706043     Document Type: Article

References (36)

1. ABO SALEM, O.M., HAYALAH, A.M., BILKEI-GORO, A., FILIPO, B., ZIMMER, A. & MÜLLER, C.E. (2004). Antinociceptive effects of A2B adenosine receptor antagonists. J. Pharmacol. Exp. Ther., 308, 356-366.
2. 2A-adenosine receptor agonists. J. Cardiovasc. Pharmacol., 30, 320-324.
3. APPEL, S., MATHOT, R.A., LANGEMEIJER, M.W., IJZERMAN, A.P. & DANHOF, M. (1995). Modeling of the pharmacodynamic interaction of an A1 adenosine receptor agonist and antagonist in vivo: N6-cyclopentyladenosine and 8-cyclopentyltheophylline. Br. J. Pharmacol., 115, 1253-1259.
4. BARRACO, R.A., JANUSZ, C.J., POLASEK, P.M., PARIZON, M. & ROBERTS, P.A. (1988). Cardiovascular effects of microinjection of adenosine into the nucleus tractus solitarius. Brain Res. Bull., 20, 129-132.
5. BARRACO, R.A., MARCANTONIO, D.R., PHILLIS, J.W. & CAMPBELL, W.R. (1987). The effects of parenteral injections of adenosine and its analogs on blood pressure and heart rate in the rat. Gen. Pharmacol., 18, 405-416.
6. BARRACO, R.A. & PHILLIS, J.W. (1991). Subtypes of adenosine receptors in the brainstem mediate opposite blood pressure responses. Neuropharmacology, 30, 403-407.
7. 2a adenosine agonists. Hypertension, 25, 564-569.
8. CASATI, C., MONOPOLI, A., FORLANI, A., BONIZZONI, E. & ONGINI, E. (1995). Telemetry monitoring of hemodynamic effects induced over time by adenosine agonists in spontaneously hypertensive rats. J. Pharmacol. Exp. Ther., 275, 914-919.
9. 1 receptors in the NTS does not affect the chemoreflex in awake rats. Am. J. Physiol. Regul. Integrative Comp. Physiol., 281, R2072-R2078.
10. 1 adenosine receptor ligands. Curr. Top. Med. Chem., 3, 369-385.
11. DUNWIDDIE, T.V. & MASINO, S.A. (2001). The role and regulation of adenosine in the central nervous system. Ann. Rev. Neurosci., 24, 31-55.
12. EVONIUK, G., VON BORSTEL, R.W. & WURTMAN, R.J. (1987). Antagonism of the cardiovascular effects of adenosine by caffeine or 8-(p-sulfophenyl) theophylline. J. Pharmacol. Exp. Ther., 240, 428-432.
13. FERRÉ, S., RUBIO, A. & FUXE, K. (1991). Stimulation of adenosine A2 receptors induces catalepsy. Neurosci. Lett., 130, 162-164.
14. 3 adenosine receptor activation triggers phosphorylation of protein kinase B and protects rat basophilic leukemia 2H3 mast cells from apoptosis. Mol. Pharamcol., 59, 76-82.
15. 2a receptor ligand. J. Nucl. Med., 41, 345-354.
16. 2 adenosine receptor antagonist in vivo. J. Pharmacol. Exp. Ther., 267, 1304-1310.
17. 2A receptors in the motor effects of caffeine after its acute and chronic administration. Neuropsychopharmacology, 28, 1281-1291.
18. 2a purinoceptor activation elicits hindlimb vasodilation primarily via a β-adrenergic mechanism. Am. J. Physiol. Heart Circ. Physiol., 278, H1775-H1782.
19. LAPPE, R.W., SHELDON, J.H. & COX, B.F. (1992). Selective adenosine-2 agonist produces both direct and reflex tachycardia in normotensive rats. J. Cardiovas. Pharmacol., 19, 460-463.
20. MATHOT, R.A., CLETON, A., SOUDIJN, W., IJZERMAN, A.P. & DANHOF, M. (1995a). Pharmacokinetic modeling of the haemodynamic effects of the A2a adenosine receptor agonist CGS 21680C in conscious normotensive rats. Br. J. Pharmacol., 114, 761-768.
21. 2 receptor antagonist 8-(3-chlorostyryl)caffeine. J. Pharmacol. Exp. Ther., 275, 245-253.
22. 2A adenosine receptor antagonist, SCH 58261, in the rat. J. Pharmacol. Exp. Ther., 285, 9-15.
23. 2A adenosine receptor antagonists - future drugs for Parkinson's disease? Drugs Future, 25, 1043-1052.
24. NATIONAL RESEARCH COUNCIL (1996). Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academy Press.
25. 2A-selective adenosine receptor antagonists. J. Med. Chem., 43, 440-448.
26. 2A receptor agonist CGS 21680. Eur. J. Pharmacol., 484, 269-275.
27. 2X purinoceptors. Am. J. Physiol. Heart Circ. Physiol., 275, H2130-H2139.
28. 1 adenosine receptors. Am. J. Physiol. Heart Circ. Physiol., 238, H1588-H1599.
29. SHRYOCK, J.C. & BELARDINELLI, L. (1997). Adenosine and adenosine receptors in the cardiovascular system: Biochemistry, physiology, and pharmacology. Ant. J. Cardiol., 79, 2-10.
30. SPYER, K.M. & THOMAS, T. (2000). A role for adenosine in modulating cardio-respiratory response: a mini-review. Brain Res. Bull., 53, 121-124.
31. 2A receptors. Nucl. Med. Biol., 24, 187-191.
32. TABRIZCHI, R (1997). Effects of adenosine and adenosine analogues on mean circulatory filling pressure and cardiac output in anesthetized rats. Naunyn-Schmiedeberg's Arch. Pharmacol., 356, 69-75.
33. TABRIZCHI, R. & BEDI, S. (2001). Pharmacology of adenosine receptors in the vasculature. Pharmacol. Ther., 91, 133-147.
34. TELLA, S.R., SCHINDLER, C.W. & GOLDBERG, S.R. (1999). Cardiovascular responses to cocaine self-administration: acute and chronic tolerance. Eur. J. Pharmacol., 383, 57-68.
35. 2a receptors in regions of the brainstem important in cardiovascular control. Neuroscience, 95, 513-518.
36. WEBB, R.L., MCNEAL JR, R.B., BARCLARY, B.W. & YASAY, G.D. (1990). Hemodynamic effects of adenosine agonists in the conscious spontaneously hypertensive rat. J. Pharmacol. Exp. Ther., 254, 1090-1099.